Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is to determine if implitapide, used in conjunction with other lipid-lowering therapies, is safe and effective when compared to placebo in lowering low-density lipoprotein cholesterol (LDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).
Epistemonikos ID: e054070e0abc9d4c2b1a150953b5fb8d17996ac5
First added on: May 04, 2024